Differentiation of Progression From Treatment Effects in High-Grade Gliomas: A Clinical Trial With Multimodality MR Imaging
Differentiation of Progression From Treatment Effects in High-Grade Gliomas: A Clinical Trial With Multimodality MR Imaging
To evaluate the efficacy of multi-modality magnetic resonance quantitative parameters in
 evaluating the treatment effects of high-grade gliomas, and to provide new biomarkers for the
 establishment of new diagnostic criteria for the identification of true and pseudoprogression
 of high-grade gliomas.
Inclusion Criteria:

 1. Patients with high-grade gliomas confirmed by pathology and have not been treated with
 concurrent chemoradiotherapy;

 2. Written informed consent is obtained.

 Exclusion Criteria:

 1. Patients not suitable for enhanced MRI scanning of patients;

 2. Patients who have not finished follow-up concurrent chemoradiotherapy or MR scanning.